Pyrazolopyrimidine fused thiazolidinone hybrids as CDK2 inhibitors: insights from pharmacophore modeling, docking, DFT and molecular dynamics simulations

DOI: 10.1016/j.molstruc.2025.142009 Publication Date: 2025-03-09T16:10:03Z